The generic product development plans (PDPs) and target product profiles (TPPs) below provide guidance to support product development activities through Phase 1 clinical development:
- PDP for Human Monoclonal Antibodies
- PDP for Small Molecule Anti-infectives
- PDP for a Generic Prophylactic Vaccine for Infectious Diseases
- TPPs for Antivirals (within the scope of the Antiviral Program for Pandemics)